Bristol myers squibb. 3 days ago · BMY | Complete Bristol Myers Squibb Co.

Bristol myers squibb -based manufacturing facility and its operations in Libertyville, Illinois, following the Nov 17, 2025 · The 340B Drug Pricing Program, designed to provide discounted medications to economically disadvantaged patients, has come under scrutiny from some of the largest pharmaceutical companies in the world. May 29, 2025 · Bristol Myers Squibb is taking a comprehensive approach by leveraging the strength of our research teams, capabilities and diverse portfolio, all grounded in causal human biology, to solve complex scientific challenges and deliver transformational medicines to patients faster. Bristol-Myers Squibb Co. Discover the latest press releases and updates from Bristol Myers Squibb, a global biopharmaceutical company dedicated to innovative therapies for serious diseases. The goal: inspire the public, and the Boston biopharmaceutical company’s more than 500 employees, with a space that reflected the global impact of 5 days ago · Latest Bristol-Myers Squibb Co (BMY:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. merged in 1989 to form what’s now one of the world’s largest pharmaceutical companies. Learn more about Bristol Myers Squibb’s key financial and product revenue information. Bristol-Myers Squibb develops, licenses, manufactures, and delivers Bristol Myers Squibb’s robust and growing presence in California is transforming the way cancer and other difficult-to-treat diseases are approached. A. Leading with innovation to deliver vital medicines worldwide. “We had a good start to 2024, with revenue growth, important advances in our pipeline and the closure of several strategically important transactions,” said Christopher Boerner, Ph. " Some of the company's focus areas include solid tumors and cancer, cardiovascular disease, and neurological and neuromuscular diseases. With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary of Bristol Myers Squibb. The company's corporate headquarters are in New York City. Each day, our employees around the world work together for patients across disease areas such as oncology, hematology, cardiovascular, neuroscience, fibrosis and immunology. Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases. Join us in our journey as we revolutionize healthcare driving scientific breakthroughs and transformative results for a better and brighter future. BMS was founded 134 years ago and in these 134 years, it has proved that it is easily one of the most reputable and trusted pharmaceutical companies. corporatefinancial-news Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases. Learn more about Bristol Myers Squibb, a global biopharma company dedicated to discover, develop and deliver innovative medicines to patients with serious diseases. Bristol Myers Squibb is led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. further extends Bristol Myers Squibb’s leadership in cell therapy Bristol Myers Squibb (NYSE: BMY) today announced that the U. Apr 26, 2023 · Libertyville, Illinois facility bolsters long-term viral vector supply with multi-product, in-house viral vector production capabilities Bristol Myers Squibb (NYSE: BMY) today announced expansion of its global cell therapy manufacturing network to enable in-house viral vector production through a U. Are you looking to invest in biopharmaceutical stocks? Find historical stock quotes and get information including opening price, stock performance and more. Apr 24, 2025 · PRINCETON, N. Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases. Get the latest Bristol-Myers Squibb Co (BMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Bristol Myers Squibb Bristol-Myers Squibb Company is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. We provide corporate giving support to organizations that assist patients and their families and caregivers, enhance healthcare, advance scientific knowledge, and support the communities where our employees 6 days ago · At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Learn more about our company's history. Investors are closely watching revenue trends and profit growth as the company navigates an evolving pharmaceutical landscape. “Our strong execution in the first quarter drove continued momentum across our Growth Portfolio and meaningful progress in the pipeline,” said Christopher Boerner, Ph. Multiple Sclerosis Foundation (MS Focus) Offers free programs and access to grants that can help address the needs of those with MS and their families. The company offers products Internships & Co-ops Use your education and experience to support nearly every area of our business, build your professional network and explore your personal development. 3 hours ago · At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Jul 1, 2025 · Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. In Cambridge, […] Jul 26, 2024 · Bristol Myers Squibb (BMY -0. Explore comprehensive information about our products including dosage and safety information. S Learn how Bristol Myers Squibb is focusing on people to bring meaningful breakthroughs, life-saving medicine and a human touch to every treatment for transforming patients’ life through science. It is the third largest pharmaceutical company in the world, and its offerings include cardiovascular and anti-cancer drugs, anti-infective agents, drugs for treating the central nervous system, diagnostic imaging agents, and dermatological products. When Bristol Myers Squibb sought to add another layer to its new state-of-the-art, 480,000-square-foot research and development center at Cambridge Crossing, the LAB at Rockwell Group was brought in to transform the lobby and pre-function area. 15 hours ago · Bayer's stock is jumping on a stroke drug trial - and so is Bristol Myers Squibb Provided by Dow Jones Nov 24, 2025, 5:37:00 AM 3 days ago · Should You Buy or Sell Bristol Myers Squibb Stock? Get The Latest BMY Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat. J. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, and Feb 2, 2024 · Bristol Myers Squibb posted fourth quarter revenues of $11. For more information about Bristol Myers Squibb, visit us at BMS. Jul 10, 2025 · Bristol Myers Squibb is undervalued despite challenges. Learn more about our medicines today. About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. We are pursuing bold science to define what's Explore Bristol Myers Squibb's ground-breaking advances in drug development at Cambridge Crossing. com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram. The company What is Bristol Myers Squibb? Bristol Myers Squibb is a pharmaceutical company founded in the United States. over the next five years, as it seeks to expand its research and manufacturing presence in the country amid U. Welcome to Bristol Myers Squibb’s BMS Medical Medical resources for healthcare professionals The resources on this page are offered by Bristol Myers Squibb to assist U. Learn more > National MS Society Offers information on all things MS and provides platforms that can help you connect with the MS community. In 2015, Bristol Myers Squibb provided more than $694 million in free medicines to more than 65,000 US patients. Jan 3, 2019 · Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on the proposed transaction and/or Bristol-Myers Squibb or Celgene, Bristol-Myers Squibb’s ability to successfully complete the proposed transaction and/or realize the expected benefits from the proposed transaction. (New York City time) on November 17, 2025, (the “Early Tender Deadline”) of the previously announced tender offers to purchase for cash its outstanding notes listed in the tables below. At Bristol Myers Squibb, we work every day to transform patients’ lives through science. 64%) Q2 2024 Earnings Call Jul 26, 2024, 8:00 a. -based manufacturing facility and its operations in Libertyville, Illinois, following the Dec 22, 2023 · These items are excluded from non-GAAP earnings and related EPS information because Bristol Myers Squibb believes they neither relate to the ordinary course of Bristol Myers Squibb’s business nor reflect Bristol Myers Squibb’s underlying business performance. Aug 26, 2024 · Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. com or follow us on LinkedIn, X, YouTube, Facebook and Instagram. 5 days ago · Company profile for Bristol-Myers Squibb Company (BMY) stock, with a description, list of executives, contact details and other key facts. We’re committed to the UK. 2 days ago · A detailed overview of Bristol-Myers Squibb Company (BMY) stock, including real-time price, chart, key statistics, news, and more. Bristol-Myers Squibb Company (BMS) is a multinational biopharmaceutical firm founded in 1887, with its corporate headquarters located in New York City. It produces chemically synthesized drugs in the form of tablets, capsules, and injections for patients facing diseases in the areas of oncology, hematology, immunology, cardiovascular, and neuroscience. View Bristol-Myers Squibb Company BMY stock quote prices, financial information, real-time forecasts, and company news from CNN. and Squibb Corp. It is considered one of the largest pharmaceutical companies in the world. Jun 1, 2020 · Bristol Myers Squibb (BMS) history, company profile (overview) and history video Bristol Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York, United States. Discover our HCP resources today. Bristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Bristol Myers Squibb | 1,761,878 followers on LinkedIn. 15 hours ago · At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Learn more. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Bristol Myers Squibb focuses on core therapeutic areas and multiple drug platforms across these areas to transform patients' lives through science and technology. 6 days ago · Bristol-Myers Squibb stands out in Big Pharma with strong sales growth and a solid dividend yield. (212) 546-4000 Fax: (212) 546-4020 Public Company Incorporated: 1900 as Bristol-Myers Company Employees: 52,600 Sales: $11 billion Stock Exchanges: New York SICs: 2834 Pharmaceutical Preparations; 2844 Perfumes, Cosmetics Bristol-Myers Squibb Company is the second largest pharmaceutical company in the world and is Dec 22, 2023 · These items are excluded from non-GAAP earnings and related EPS information because Bristol Myers Squibb believes they neither relate to the ordinary course of Bristol Myers Squibb’s business nor reflect Bristol Myers Squibb’s underlying business performance. D Bristol Myers Squibb is a biopharmaceutical company that says its mission "is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. stock news by MarketWatch. Bristol Myers Squibb is committed to conscientious corporate citizenship and supports initiatives that make a positive impact globally. 6% change. Bristol-Myers Squibb’s 7% share price pop this past month stands out after a rough start to the year, as longer 1 day ago · Neo Ivy Capital Management bought a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). Nov 14, 2025 · Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar 6 days ago · Bristol-Myers Squibb (BMY) shares have had a mixed performance over the past month, gaining around 7%. Recently, legal representatives from major companies such as Eli Lilly, Novartis, and Bristol Myers Squibb voiced their concerns during a judicial panel regarding the program’s effectiveness Jul 26, 2024 · About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. healthcare professionals in caring for patients and conducting research with BMS medicines. The Devens site is a critical 5 days ago · Bristol Myers Squibb (BMY) has recently been on Zacks. Get Bristol-Myers Squibb Co (BMY) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Life at BMS A place to call your own At Bristol Myers Squibb, you’ll join a diverse, high-achieving team united by a common mission. 3%) reported results that beat expectations across both its Growth and Legacy portfolios but lowered EPS guidance due to one-time R&D charges and Mar 10, 2025 · Bristol-Myers Squibb (BMS) is one of the largest pharmaceutical companies in the world, with 25,000 employees and $19. Bristol Myers Squibb has been striving hard to improve lives by providing better healthcare solutions since the early 1800s. m. Dec 2, 2021 · At Bristol Myers Squibb, we’re inspired by a single vision – transforming patients’ lives through science. com or follow us on LinkedIn, X, YouTube, Facebook, and Instagram. Bristol-Myers Squibb Co (BMS) is a biopharmaceutical company engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of innovative biopharmaceutical products. It focuses on discovering, developing and delivering innovative medicines in different therapeutic areas, including oncology and hematology, immunology and cardiovascular disease, fibrotic diseases, and 3 days ago · BMY | Complete Bristol Myers Squibb Co. Get Bristol-Myers Squibb Co (BMY:NYSE) real-time stock quotes, news, price and financial information from CNBC. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. The Business Development team at Bristol Myers Squibb promotes pharma partnerships to discover, develop and deliver transformational medicines to patients. May 18, 2018 · Bristol-Myers Squibb Company 345 Park Avenue New York, New York, 10154 U. View (BMY) real-time stock price, chart, news, analysis, analyst reviews and more. The company is focused on the research, development, manufacturing, and distribution of innovative medicines aimed at addressing serious diseases. At Bristol Myers Squibb, we hold ourselves to the highest standards of moral and ethical behavior and our values and principles guide every decision we make. Learn how a single touch can transform patients’ lives in Bristol Myers Squibb’s 2022 Annual Report. In 2020, our total economic footprint in the UK economy was an At Bristol Myers Squibb, we hold ourselves to the highest standards of moral and ethical behavior and our values and principles guide every decision we make. S. In Massachusetts, we operate a number of sites, spanning across both R&D and manufacturing. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. You’ll grow and thrive through opportunities that are uncommon in scale and scope. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. . 5 days ago · A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Explore our strategic partnerships in the R&D field. Bristol Myers Squibb provides information and resources to healthcare providers (HCP) about our medicines with the goal of improving the health of patients. Discover how Bristol Myers Squibb's groundbreaking research in drug discovery is transforming patient lives through science across hematology, oncology, immunology, cardiovascular disease and neuroscience. Read what BMY stock has to offer for the long, mid, and short term. At Bristol Myers Squibb, we seek to improve the lives of patients by offering resources & programs for both patients & caregivers. The institutional investor bought 14,187 shares of th Jun 8, 2023 · The company’s third commercial CAR T manufacturing facility in the U. -- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today reports results for the first quarter of 2025. Explore comprehensive information about Bristol Myers Squibb products including dosage and safety information. May 6, 2025 · Bristol Myers Squibb said on Monday it will invest $40 billion in the U. Nov 5, 2025 · Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines, research innovation and other news as we work to support patients fighting serious disease. It produces pharmaceuticals, vitamins, medical devices, and beauty and personal-care products. Jun 2, 2025 · About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Learn how BMY stock's strong pipeline, cash flow, and growth strategies offset patent expiries. Explore our resources today. From the scientists behind the microscope to the analysts behind the data, everyone at BMS is dedicated to making an impact. Bristol Myers Squibb wishes to advance science through supporting novel, independent research that addresses unmet need surrounding our products and therapeutic areas. View real-time stock prices and stock quotes for a full financial overview. Bristol Myers Squibb’s collaborative partnerships are critical to our ability to provide transformative medicines to patients. Reinforce your resume with real-world experience Summer Internships 10-12 week summer experiences Opportunities in all Bristol Myers Squibb functional areas Applications accepted for summer internships: August-March Co-ops Dec 11, 2023 · About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. The company offers its products in therapy areas such as oncology, hematology, immunology, cardiovascular, and neuroscience. Learn more about qualifying for help paying for medications. The Leadership Team at Bristol-Myers Squibb drives the strategic direction and operational excellence of the organization, ensuring the development and delivery of innovative therapies for serious diseases. 5 days ago · Bristol Myers Squibb has accepted Notes for purchase according to the Acceptance Priority Procedures and the terms and conditions described in the Offer to Purchase. Other locations 4 days ago · Bristol-Myers Squibb Company (NYSE:BMY) (-1. com's list of the most searched stocks. During this period, the Zacks Jul 28, 2025 · Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Apr 26, 2023 · About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. 9 billion, an increase of 8%, or 10% when adjusted for foreign exchange impacts, primarily driven by the Growth Portfolio and Eliquis, partially offset by generic erosion of Sprycel due to the loss of exclusivity. Learn more about Bristol Myers Squibb's science and core of work in clinical researcher, pharmaceutical development and innovation. 5 billion, an increase of 1% both on a reported and when adjusted for foreign exchange basis, primarily due to higher sales of new product portfolio, as well as Eliquis and Opdivo, partially offset by lower sales of Revlimid. Bristol Myers Squibb posted third quarter revenues of $11. Read why BMY earns a Strong Buy upgrade. In 2020, our total economic footprint in the UK economy was an Dec 18, 2023 · Bristol-Myers Co. Oct 31, 2024 · Bristol Myers Squibb posted third quarter revenues of $11. Click here to read an analysis of BMY stock now. Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals. Feb 6, 2025 · Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Nov 14, 2025 · A closely watched next-generation blood thinner being developed by Bristol Myers Squibb and Johnson & Johnson failed in one of three late-stage trials. Jan 23, 2024 · Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc. Nov 10, 2025 · View SEC filings (including Annual 10-K, Quarterly, Current report 8-k, Proxy, Section 16 and Registration Statements and other filings) from 1994 to present. com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. Learn how to check your eligibility, see which medicines are available, and apply online or by phone. From the scientists behind the microscope to the analysts behind the data, everyone at BMS is working to make an impact. That work inspires some of the most interesting Learn more about Chris Boerner, PhD, board chair and chief executive officer at Bristol Myers Squibb. [1] BMSPAF is a charitable organization that helps eligible patients who need temporary help obtaining certain Bristol Myers Squibb medicines. Apr 25, 2024 · PRINCETON, N. Jul 28, 2025 · Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for lupus Bain Capital leads $300 million financing commitment Bristol Myers Squibb (NYSE: BMY, “BMS”) and Bain Capital today announced the creation of a new independent biopharmaceutical company (“NewCo”) focused on developing new Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and scientific innovation, Our stories offers a window into the work our employees do every day for patients. Learn how a single touch can transform patients’ lives in Bristol Myers Squibb’s 2021 Annual Report. 22 billion revenue and a higher 2025 sales outlook, driven by strong demand for Reblozyl, Camzyos, and Breyanzi. -- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today reports results for the first quarter of 2024, which reflect meaningful progress in the company's growth portfolio and pipeline. Bristol Myers Squibb currently has two state-of-the-art facilities in Massachusetts: a R&D research center in Cambridge and a cell therapy and biologics development and manufacturing site in Devens. Bristol Myers Squibb also announced that it is (i) decreasing the Find information and tools for investors, stockholders and financial analysts, including share and dividend information, acquisition-related information, latest news and corporate reporting. Bristol-Myers Squibb Company is comprised of four core businesses: pharmaceuticals, consumer products, medical devices, and nutritional products. For product side-effect inquiries call (800) 721-5072. Dec 31, 2022 · Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. At Bristol Myers Squibb, your work helps people prevail over serious diseases. Learn more About Bristol Myers Squibb > Bristol Myers Squibb is a biopharmaceutical company operating worldwide, specializing in the research, development and manufacturing of innovative medicines. - from its founding year to major milestones, acquisitions, leadership changes, and growth highlights. BMS operates globally, with facilities in numerous countries, and is particularly recognized for Read how current events happening around the world impact Bristol Myers Squibb's work and our patients. Learn about global biopharmaceutical innovator Bristol Myers Squibb, helping millions to fight cancer, cardiovascular disease, HIV/AIDS, and more. “We are advancing our multi-year Visit the Bristol Myers Squibb newsroom & stay up to date with our most current news as we continue to make a difference in the lives of our patients. Nov 3, 2025 · Bristol-Myers Squibb Company is a global biopharmaceutical company. Discover the mission, vision, values and commitment of Bristol Myers Squibb, and our dedication to discovering, developing and delivering innovative medicines. Our workforce has the agility and creativity of an entrepreneurial biotech while being bolstered by the extensive resources and expertise of our global network. You’ll pursue innovative ideas while advancing professionally alongside some of the brightest minds in biopharma. The company faces challenges ahead, as analysts suggest it needs to boost the revenues of products aside from a few top performers and it fends off litigation by people who suffered injuries from using their products. 7%, compared to the Zacks S&P 500 composite's -0. Nov 17, 2025 · Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol Myers Squibb”), today announced the early participation results, as of 5:00 p. Dec 9, 2024 · Learn more about the science behind cell therapy and ongoing research at Bristol Myers Squibb here. Through our work, we help millions of people around the world in therapeutic areas including oncology, immunology and hematology, as well as cardiovascular Learn how your work at Bristol Myers Squibb helps people prevail over serious diseases. Contact Bristol Myers Squibb through our contact form, customer relations line or live chat. For Bristol Myers Squibb to be seen as a worldwide leader in supporting innovative, high quality medical education that closes gaps in HCP knowledge, strengthens their professional competence and improves patient health outcomes. Oct 30, 2025 · Latest News November 18, 2025 Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers November 17, 2025 Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers November 14, 2025 Update on Phase 3 Librexia ACS Trial May 18, 2018 · Bristol-Myers Squibb Company 345 Park Avenue New York, New York, 10154 U. Read about Bristol Myers Squibb’s decades-long leadership in cardiovascular disease research and how we remain committed to pioneering life-changing therapies. Discover patient education and resources for a variety of therapeutic areas that Bristol Myers Squibb focuses on. Food and Drug Administration (FDA) has approved commercial production at the company’s newest cell therapy manufacturing facility in Devens, Massachusetts. Oct 30, 2025 · Latest News November 18, 2025 Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers November 17, 2025 Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers November 14, 2025 Update on Phase 3 Librexia ACS Trial May 27, 2025 · Bristol-Myers Squibb's financial position improved, it raised both its EPS guidance and revenue expectations, and Opdivo's received approval. ® (“Mirati”). “The closing of the Mirati transaction is a significant milestone in Learn about the history of Bristol-Myers Squibb Co. 4 billion in revenue in 2016. See our latest analysis for Bristol-Myers Squibb. Oct 30, 2025 · Bristol Myers beats Q3 forecasts with $12. Over the past month, shares of this biopharmaceutical company have returned +5. , board chair and chief executive officer, Bristol Myers Squibb. Multiple sclerosis (MS) is a nervous system disease that affects the brain and spinal cord. Meet the executive Board of Directors at Bristol Myers Squibb, the biopharmaceutical company's decision-making body who also act as advisors and counselors to our senior management. Nov 11, 2025 · Bristol-Myers Squibb (BMY) grabbed investor attention after releasing its third-quarter results, which showed a sharp rise in net income and higher revenue guidance for 2025. D. Nov 17, 2025 · Bristol-Myers Squibb Company, American biopharmaceutical company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887. oxpgl lzinu myfmr urnjuey gxjt ppf tytsy ivdsky gxl wmqr lfguq bqse oaelj snrr abkny